Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study.

Satoshi MotoyaKenji WatanabeHaruhiko OgataTakanori KanaiToshiyuki MatsuiYasuo SuzukiMitsuhiro ShikamuraKenkichi SugiuraKazunori OdaTetsuharu HoriTakahiro ArakiMamoru WatanabeToshifumi Hibi

Published in: PloS one (2019)

ClinicalTrials.gov: NCT02039505.

Keyphrases

double blind
ulcerative colitis
placebo controlled
clinical trial
phase iii
phase ii
study protocol
open label